Clinical Neutral Vendor Managed Services (Ref: 2021/S 000-025285)
Background
In response to challenges posed by the COVID-19 pandemic, winter pressures, and a shortage of specialised clinical staff, the Clinical Neutral Vendor Managed Services framework addresses the critical priority of reducing the backlog of patients awaiting treatment.
This framework provides a comprehensive suite of core and support services, delivered either in-trust or externally, aiming to decrease referral-to-treatment waiting times and enhance patient care. Awarded as a single lot, the framework encompasses fully managed clinical services, both outsourced and insourced, from proven providers with expertise across a diverse range of clinical and ancillary services. Services offered adhere to the highest industry standards, empowering customers to treat patients within their local communities.
Benefits
- Access to the best technology and solutions in the market irrespective of OEM
- Commercial efficiencies gained through proven managed services and supply chain excellence
- Reduction of administrative burden with turnkey capabilities
- Cost transparency through a clear pricing structure
- The ability to benchmark providers without the need to approach each supplier individually or conduct a further/mini-competition
Start date
End date
Extensions
Contract type
Framework Agreement
Framework owner
ABI
Award type
Further competition
Direct award with partial competition
Lots
Single Lot
List of suppliers and awarded lots
- Chrystal Consulting Ltd
- Ergea UK and Ireland Ltd
- Genmed.Me Ltd
- Philips Healthcare
- Siemens Healthcare Ltd
- Vamed Management
Contact name
Contact email
Contact number
Access the framework documents
If you have a login to our sharepoint, you can access the framework documents below.